General
Preferred name
MAFENIDE ACETATE
Synonyms
Mafenide (Acetate) ()
Sulfamylon ()
P&D ID
PD003172
CAS
13009-99-9
Tags
available
drug
Drug Status
approved
Max Phase
4.0
Drug indication
osteomyelitis
First approval
1969
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION Mafenide Acetate is an effective sulfonamide-type antimicrobial agent used for burn wounds. Mafenide Acetate shows activity against both Gram-positive and Gram-negative organisms, including Pseudomonas aeruginosa, via inhibition of nucleotide synthesis[1][2].
PRICE 80
DESCRIPTION Mafenide is a bacteriostatic antibiotic with a broad activity against Gram positive, Gram negative bacteria and Clostridia. Mafenide acetate penetrates eschar and prevents heavy colonization in burn wounds. (BOC Sciences Bioactive Compounds)
DESCRIPTION Mafenide Acetate is a sulfonamide-type medication inhibits the enzyme carbonic anhydrase and is used as topical anti-infective, especially in burn therapy. (TargetMol Bioactive Compound Library)
Compound Sets
7
BOC Sciences Bioactive Compounds
ChEMBL Approved Drugs
ChEMBL Drugs
MedChem Express Bioactive Compound Library
NIH Clinical Collections (NCC)
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
External IDs
18
Properties
(calculated by RDKit )
Molecular Weight
246.07
Hydrogen Bond Acceptors
4
Hydrogen Bond Donors
3
Rotatable Bonds
2
Ring Count
1
Aromatic Ring Count
1
cLogP
-0.12
TPSA
123.48
Fraction CSP3
0.22
Chiral centers
0.0
Largest ring
6.0
QED
0.67
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Target
antibiotic
Bacterial
Fungal
Carbonic Anhydrase
Pathway
Microbiology/virology
Anti-infection
Solubility
Soluble in DMSO
Source data